Imunon, Inc. (NASDAQ:IMNN - Free Report) - Investment analysts at HC Wainwright issued their Q1 2024 earnings estimates for Imunon in a research report issued to clients and investors on Monday...
Imunon, Inc. (NASDAQ:IMNN - Get Free Report) saw a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 449,100 shares, a drop of 8.6% from...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Conference Call Begins Today at 10:00 a.m. Eastern Time LAWRENCEVILLE, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
IMNN stock results show that Imunon beat analyst estimates for earnings per share the fourth quarter of 2023.
The post IMNN Stock...